Encompass Health Corporation
Encompass Health Corporation Fundamental Analysis
Encompass Health Corporation (EHC) shows moderate financial fundamentals with a PE ratio of 18.83, profit margin of 9.54%, and ROE of 22.58%. The company generates $6.0B in annual revenue with strong year-over-year growth of 11.91%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 70.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze EHC's fundamental strength across five key dimensions:
Efficiency Score
WeakEHC struggles to generate sufficient returns from assets.
Valuation Score
ModerateEHC shows balanced valuation metrics.
Growth Score
ExcellentEHC delivers strong and consistent growth momentum.
Financial Health Score
ExcellentEHC maintains a strong and stable balance sheet.
Profitability Score
ModerateEHC maintains healthy but balanced margins.
Key Financial Metrics
Is EHC Expensive or Cheap?
P/E Ratio
EHC trades at 18.83 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EHC's PEG of 3.89 indicates potential overvaluation.
Price to Book
The market values Encompass Health Corporation at 3.31 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 7.51 times EBITDA. This is generally considered low.
How Well Does EHC Make Money?
Net Profit Margin
For every $100 in sales, Encompass Health Corporation keeps $9.54 as profit after all expenses.
Operating Margin
Core operations generate 17.74 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.58 in profit for every $100 of shareholder equity.
ROA
Encompass Health Corporation generates $7.99 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Encompass Health Corporation produces operating cash flow of $1.18B, showing steady but balanced cash generation.
Free Cash Flow
Encompass Health Corporation produces free cash flow of $441.02M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $4.38 in free cash annually.
FCF Yield
EHC converts 4.12% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.83
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.89
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.31
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.80
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.08
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.08
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.23
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How EHC Stacks Against Its Sector Peers
| Metric | EHC Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.83 | 29.45 | Better (Cheaper) |
| ROE | 22.58% | 779.00% | Weak |
| Net Margin | 9.54% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.08 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 1.08 | 4.65 | Neutral |
| ROA | 7.99% | -19344.00% (disorted) | Weak |
EHC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Encompass Health Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
14.46%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
24.63%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
54.84%
Industry Style: Defensive, Growth, Innovation
High Growth